Special Article: Reduction In Fatal Pulmonary Embolism And Venous
Thrombosis By Perioperative Administration Of Subcutaneous Heparin:
Overview of Results of Randomized Trials in General, Orthopedic, and
Urologic Surgery.
Use of the Greenfield filter to prevent fatal pulmonary embolism
associated with total hip and knee arthroplasty.
Heparin and low mol wt heparin for prevention of DVT.
Harenberg-J; Heene-DL; Thromb-Res. 1990 Aug 1; 59(3): 639-50
Prevention of fatal pulmonary embolism in patients with fractures of the
neck of the femur.
Dihydroergotamine/heparin in the prevention of deep-vein thrombosis after
total hip replacement. A controlled, prospective, randomized
multicenter trial [see comments
Comparison of warfarin and external pneumatic compression in prevention
of venous thrombosis after total hip replacement.
Death and thromboembolic disease after total hip replacement. A series of
1162 cases with no routine chemical prophylaxis [see comments.
Efficacy of deep venous thrombosis prophylaxis in trauma patients and
identification of high-risk groups.
Prophylaxis for the prevention of venous thromboembolism after total knee
arthroplasty. A comparison between unfractionated and low-molecular-weight
heparin.
Original Articles: A Comparison Of Subcutaneous Low-Molecular-Weight
Heparin With Warfarin Sodium For Prophylaxis Against Deep-Vein
Thrombosis After Hip Or Knee Implantation.
Efficacy of deep venous thrombosis prophylaxis in trauma patients and
identification of high-risk groups.
Warfarin prophylaxis to prevent mortality from pulmonary embolism after
total hip replacement.
Prevention of venous thrombosis after total hip arthroplasty.
Antithrombin III and low-dose heparin compared with dextran 40.
Prevention of venous thrombosis after total knee arthroplasty. Comparison
of antithrombin III and low-dose heparin with dextran.
A randomized controlled trial of a low-molecular-weight heparin
(enoxaparin) to prevent deep-vein thrombosis in patients
undergoing elective hip surgery.
Survey of prophylaxis against venous thromboembolism in adults undergoing hip
surgery.
Low-molecular-weight heparinoid compared with warfarin for
prophylaxis of deep-vein thrombosis in patients who are operated on
for fracture of the hip. A prospective, randomized trial.
Aspirin prophylaxis and surveillance of pulmonary embolism
and deep vein thrombosis in total hip arthroplasty.
Prophylaxis of deep-vein thrombosis after total hip replacement.
Dextran and external pneumatic compression compared with 1.2 or 0.3
gram of aspirin daily.
Low-molecular-weight heparinoid compared with warfarin for prophylaxis
of DVT in patients who are operated on for fracture of the hip.
Prevention of DVT and PE after THR. Comparison of low-molecular-weight
heparin and unfractionated heparin.
Prevention of DVT after elective hip surgery. A randomized trial
comparing low molecular weight heparin with standard heparin.
Prevention of deep vein thrombosis after hip replacement: randomised
comparison between unfractionated heparin and low molecular weight heparin
[published erratum appears in BMJ 1991 Nov 16;303(6812);1243 [see
Eriksson BI, Kalebo P, Anthmyr BA, Wadenvik H, Tengborn L,
Risberg B. Prevention of deep-vein thrombosis and pulmonary embolism
after total hip replacement. J Bone Joint Surg Am. 1991; 73:484-493.
Use of enoxaparin, a low-molecular-weight heparin, and unfractionated
heparin for the prevention of deep venous thrombosis after elective hip
replacement. A clinical trial comparing efficacy and safety. Enoxaparin
Clinical Trial Group.
Intermittent Pneumatic Compression to prevent DVT during and after THR.
Effects of epidural anesthesia on the incidence of DVT after TKR.
The effect of intravenous fixed-dose heparin during total hip
arthroplasty on the incidence of deep-vein thrombosis. A randomized,
double-blind trial in patients operated on with epidural anesthesia and
controlled hypotension.
